Insulin resistance, polycystic ovary syndrome and metformin (Q33781663)

29 July 2017

Insulin resistance, polycystic ovary syndrome and metformin (English)

1 reference

polycystic ovary syndrome

29 July 2017

1 reference

1 reference

1 reference

1 reference

Pugeat M

1

1 reference

PubMed ID

10576524

29 July 2017

Ducluzeau PH

series ordinal

2

1 reference

PubMed ID

10576524

29 July 2017

language of work or name

1 reference

1 January 1999

1 reference

29 July 2017

1 reference

29 July 2017

58 Suppl 1

1 reference

29 July 2017

41-6; discussion 75-82

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199958001-00010

29 July 2017

0 references

cites work

Polycystic ovary syndrome

1 reference

12 December 2020

Diet-induced changes in sex hormone binding globulin and free testosterone in women with normal or polycystic ovaries: correlation with serum insulin and insulin-like growth factor-I

1 reference

12 December 2020

Decreased serum leptin concentrations during metformin therapy in obese women with polycystic ovary syndrome.

1 reference

12 December 2020

Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones

1 reference

12 December 2020

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

1 reference

12 December 2020

Evidence for a single gene effect causing polycystic ovaries and male pattern baldness

1 reference

12 December 2020

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

1 reference

12 December 2020

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

12 December 2020

The genetics of polycystic ovary syndrome

1 reference

12 December 2020

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

1 reference

12 December 2020

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

1 reference

12 December 2020

Effect of body weight reduction on plasma androgens in obese, infertile women.

1 reference

12 December 2020

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.

1 reference

12 December 2020

Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome

1 reference

12 December 2020

Polycystic ovaries--a common finding in normal women

1 reference

12 December 2020

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

12 December 2020

Insulin-sensitising agents in polycystic-ovary syndrome.

1 reference

12 December 2020

1 reference

12 December 2020

Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome.

1 reference

12 December 2020

Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology

1 reference

12 December 2020

Can metformin reduce insulin resistance in polycystic ovary syndrome?

1 reference

12 December 2020

[Hyperandrogenism in hirsute and obese women. Effects of a low calorie diet].

1 reference

12 December 2020

Effects of weight loss on the hormonal profile in obese, infertile women

1 reference

12 December 2020

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

12 December 2020

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

12 December 2020

Metformin in management of pregnant insulin-independent diabetics

1 reference

12 December 2020

Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

12 December 2020

Endocrine consequences of weight loss in obese, hyperandrogenic, anovulatory women.

1 reference

12 December 2020

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

12 December 2020

Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss

1 reference

12 December 2020

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

1 reference

12 December 2020

17 alpha-Hydroxyprogesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss

1 reference

12 December 2020

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome.

1 reference

12 December 2020

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

12 December 2020

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

12 December 2020

Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens

1 reference

12 December 2020

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

12 December 2020

10.2165/00003495-199958001-00010

Identifiers

DOI

0 references

Dimensions Publication ID

0 references

1 reference

PubMed ID

10576524